Multimodality MR imaging assessment of myocardial viability: combination of first-pass and late contrast enhancement to wall motion dynamics and comparison with FDG PET-initial experience

Radiology. 2000 Dec;217(3):729-36. doi: 10.1148/radiology.217.3.r00dc18729.

Abstract

Purpose: To combine three magnetic resonance (MR) imaging modalities-dobutamine stress cine, first pass, and late contrast material-enhanced T1-weighted imaging-and to compare the results with 2-[fluorine 18]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) in the assessment of unviable myocardium in coronary artery disease.

Materials and methods: Ten patients with multivessel coronary artery disease underwent MR imaging before and 6 months after bypass surgery. Left ventricular cine MR imaging was performed at rest and during dobutamine infusion. Inversion-recovery gradient-echo images were obtained to study myocardial contrast enhancement at first pass and 5 minutes later. FDG PET was performed with orally administered acipimox before surgery.

Results: With dobutamine cine MR imaging, unviable myocardium was detected with a sensitivity of 79% and a specificity of 93%; postoperative wall thickening was the standard. First-pass analysis increased these values to 97% and 96%; analysis of late enhancement with T1-weighted imaging, to 62% and 98%. FDG PET had a sensitivity of 81% and a specificity of 86%.

Conclusion: The combination of first-pass enhancement analysis and wall motion assessment with stress significantly increases the specificity of MR imaging in the detection of unviable sectors.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Cardiotonic Agents
  • Coronary Disease / diagnostic imaging*
  • Dobutamine
  • Female
  • Fluorodeoxyglucose F18*
  • Heart Function Tests
  • Humans
  • Hypertrophy, Left Ventricular / diagnostic imaging
  • Magnetic Resonance Imaging / methods*
  • Male
  • Middle Aged
  • Myocardial Contraction*
  • Radiopharmaceuticals*
  • Sensitivity and Specificity
  • Tomography, Emission-Computed*
  • Ventricular Function, Left
  • Ventriculography, First-Pass

Substances

  • Cardiotonic Agents
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Dobutamine